{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:44Z","timestamp":1791644324713,"version":"4.3.4"},"reference-count":290,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bbadis.2023.166714","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T20:36:25Z","timestamp":1680726985000},"page":"166714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective"],"prefix":"10.1016","volume":"1869","author":[{"given":"Mehrdad","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Arad","family":"Zandieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setayesh","family":"Ziaolhagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mojtabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh Hasani","family":"Sadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Khazaei","family":"Koohpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghanbarirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin","family":"Haghighatfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Behroozaghdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokooh","family":"Salimimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Taheriazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166714_bb0005","series-title":"Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation","first-page":"234","volume":"32(4-6)","author":"Hybertson","year":"2011"},{"key":"10.1016\/j.bbadis.2023.166714_bb0010","series-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","first-page":"9926","volume":"91(21)","author":"Moi","year":"1994"},{"key":"10.1016\/j.bbadis.2023.166714_bb0015","series-title":"Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD (P) H: quinone oxidoreductase1 gene","first-page":"14960","volume":"93(25)","author":"Venugopal","year":"1996"},{"issue":"17","key":"10.1016\/j.bbadis.2023.166714_bb0020","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"17","key":"10.1016\/j.bbadis.2023.166714_bb0025","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.0305902101","article-title":"Small maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway","volume":"101","author":"Motohashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030436","article-title":"Conservation of the Keap1-Nrf2 system: an evolutionary journey through stressful space and time","volume":"22","author":"Fuse","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166714_bb0040","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0045","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166714_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2443.2001.00469.x","article-title":"Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription","volume":"6","author":"Katoh","year":"2001","journal-title":"Genes Cells"},{"issue":"24","key":"10.1016\/j.bbadis.2023.166714_bb0055","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1128\/MCB.25.24.10895-10906.2005","article-title":"The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation","volume":"25","author":"Nioi","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MCB.00785-15","article-title":"The mediator subunit MED16 transduces NRF2-activating signals into antioxidant gene expression","volume":"36","author":"Sekine","year":"2016","journal-title":"Mol. Cell. Biol."},{"issue":"32","key":"10.1016\/j.bbadis.2023.166714_bb0065","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1038\/onc.2012.388","article-title":"Nrf2 is controlled by two distinct \u03b2-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity","volume":"32","author":"Chowdhry","year":"2013","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166714_bb0070","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-12-3386","article-title":"RXR\u03b1 inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2","volume":"73","author":"Wang","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbadis.2023.166714_bb0080","series-title":"Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury","first-page":"116","volume":"20(2)","author":"Ashrafizadeh","year":"2020"},{"key":"10.1016\/j.bbadis.2023.166714_bb0085","series-title":"Melatonin as a potential modulator of Nrf2","first-page":"11","volume":"34(1)","author":"Ahmadi","year":"2020"},{"key":"10.1016\/j.bbadis.2023.166714_bb0090","series-title":"Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery","first-page":"349","volume":"10(3)","author":"Mirzaei","year":"2021"},{"key":"10.1016\/j.bbadis.2023.166714_bb0095","article-title":"Role of Nrf2 and its activators in respiratory diseases","volume":"2019","author":"Liu","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb0105","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.3390\/molecules190710074","article-title":"Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway","volume":"19","author":"Keum","year":"2014","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1\u2013Nrf2\u2013ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbadis.2023.166714_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2","volume":"88","author":"Canning","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166714_bb0120","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2\u2013Keap1 signaling pathway in cancer","volume":"27","author":"Jaramillo","year":"2013","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0130","series-title":"The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway","first-page":"110234","volume":"127","author":"Farkhondeh","year":"2020"},{"key":"10.1016\/j.bbadis.2023.166714_bb0135","series-title":"Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance","first-page":"105575","volume":"167","author":"Mirzaei","year":"2021"},{"key":"10.1016\/j.bbadis.2023.166714_bb0140","series-title":"Therapeutic and biological activities of berberine: the involvement of Nrf2 signaling pathway","first-page":"1575","volume":"121(2)","author":"Ashrafizadeh","year":"2020"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0145","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0155","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.7150\/ijbs.69714","article-title":"Forsythoside a mitigates Alzheimer's-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2\/GPX4 Axis activation","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2023.166714_bb0160","article-title":"Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0165","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41598-022-07065-y","article-title":"DJ-1 upregulates the Nrf2\/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia","volume":"12","author":"Liao","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0170","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101470R","article-title":"NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury","volume":"36","author":"Kim","year":"2022","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10020-022-00442-3","article-title":"Eriodictyol ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102224","article-title":"Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: involvement of NRF2 regulation","volume":"49","author":"Yuan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9304383","article-title":"High level of uric acid promotes atherosclerosis by targeting NRF2-mediated autophagy dysfunction and ferroptosis","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6551069","article-title":"GPX4-regulated ferroptosis mediates S100-induced experimental autoimmune hepatitis associated with the Nrf2\/HO-1 signaling pathway","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153894","article-title":"Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway","volume":"96","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2023.166714_bb0200","first-page":"428","article-title":"Photothermal therapy with regulated Nrf2\/NF-\u03baB signaling pathway for treating bacteria-induced periodontitis","volume":"9","author":"Tian","year":"2022","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1541-7786.MCR-21-0342","article-title":"The E3 ligase MIB1 promotes proteasomal degradation of NRF2 and sensitizes lung cancer cells to ferroptosis","volume":"20","author":"Wang","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jid.2021.05.025","article-title":"CAMKK2 defines ferroptosis sensitivity of melanoma cells by regulating AMPK\u2013NRF2 pathway","volume":"142","author":"Wang","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0215","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/acsami.1c22861","article-title":"Enhanced ROS-boosted phototherapy against pancreatic cancer via Nrf2-mediated stress-defense pathway suppression and ferroptosis induction","volume":"14","author":"Tao","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbadis.2023.166714_bb0220","series-title":"Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome","first-page":"368","volume":"10(4)","author":"Lumsden","year":"2013"},{"key":"10.1016\/j.bbadis.2023.166714_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105520","article-title":"Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications","volume":"170","author":"Lu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb0230","series-title":"Diabetes-related microvascular and macrovascular diseases in the physical therapy setting","first-page":"1322","volume":"88(11)","author":"Cade","year":"2008"},{"key":"10.1016\/j.bbadis.2023.166714_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2023.166714_bb0240","article-title":"How to prevent the microvascular complications of type 2 diabetes beyond glucose control","volume":"356","author":"Valencia","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.bbadis.2023.166714_bb0245","series-title":"Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes\u2014United States and Puerto Rico, 2000\u20132014","first-page":"1165","volume":"66(43)","author":"Burrows","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0250","series-title":"Trends in chronic kidney disease in China","first-page":"905","volume":"375(9)","author":"Zhang","year":"2016"},{"key":"10.1016\/j.bbadis.2023.166714_bb0255","series-title":"Mechanistic insight and management of diabetic nephropathy: recent progress and future perspective","volume":"2017","author":"Xue","year":"2017"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0260","first-page":"49","article-title":"Diabetic kidney disease: world wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2016","journal-title":"J. Nephropharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0265","series-title":"Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease","first-page":"456","volume":"268(5)","author":"Stenvinkel","year":"2010"},{"key":"10.1016\/j.bbadis.2023.166714_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1010268","article-title":"Mitochondrial dysfunction and diabetic nephropathy: nontraditional therapeutic opportunities","volume":"2021","author":"Zhang","year":"2021","journal-title":"J.Diabetes Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb0275","series-title":"Update of pathophysiology and management of diabetic kidney disease","first-page":"662","volume":"117(8)","author":"Lin","year":"2018"},{"key":"10.1016\/j.bbadis.2023.166714_bb0280","series-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas","first-page":"107843","volume":"157","author":"Saeedi","year":"2019"},{"key":"10.1016\/j.bbadis.2023.166714_bb0285","series-title":"Mechanisms of diabetic complications","first-page":"137","volume":"93(1)","author":"Forbes","year":"2013"},{"key":"10.1016\/j.bbadis.2023.166714_bb0290","series-title":"Oxidative stress as a major culprit in kidney disease in diabetes","first-page":"1446","volume":"57(6)","author":"Forbes","year":"2008"},{"key":"10.1016\/j.bbadis.2023.166714_bb0295","series-title":"Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities","first-page":"537","volume":"12(4)","author":"Sivitz","year":"2010"},{"key":"10.1016\/j.bbadis.2023.166714_bb0300","series-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","first-page":"1901","volume":"24(11)","author":"Sharma","year":"2013"},{"key":"10.1016\/j.bbadis.2023.166714_bb0305","series-title":"Diabetic kidney disease: challenges, progress, and possibilities","first-page":"2032","volume":"12(12)","author":"Alicic","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154834","article-title":"Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy","volume":"122","author":"Chen","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2023.166714_bb0315","series-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2020","first-page":"S135","volume":"43(Suppl 1)","author":"care","year":"2020"},{"key":"10.1016\/j.bbadis.2023.166714_bb0320","series-title":"CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease","first-page":"361","volume":"14(6)","author":"Anders","year":"2018"},{"key":"10.1016\/j.bbadis.2023.166714_bb0325","series-title":"Early renal function decline in type 2 diabetes","first-page":"78","volume":"7(1)","author":"Pavkov","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119635","article-title":"Diabetic nephropathy: a twisted thread to unravel","volume":"278","author":"Dagar","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2023.166714_bb0335","series-title":"The pathogenesis of diabetic nephropathy","first-page":"444","volume":"4(8)","author":"Dronavalli","year":"2008"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166714_bb0340","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db21-0050","article-title":"The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK\/PPAR\u03b1\/CPT1b pathway","volume":"70","author":"Wu","year":"2021","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0345","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.kint.2021.04.036","article-title":"Receptor activator of NF-\u03baB mediates podocyte injury in diabetic nephropathy","volume":"100","author":"Ke","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13098-021-00744-2","article-title":"Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response","volume":"13","author":"Lin","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0355","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jdi.13534","article-title":"CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy","volume":"12","author":"Zheng","year":"2021","journal-title":"J. Diabetes Investig."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0360","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5008","article-title":"Apelin-13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis","volume":"48","author":"Gao","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0365","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10020-021-00365-5","article-title":"METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of \u03b1-klotho","volume":"27","author":"Li","year":"2021","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12967-021-02964-6","article-title":"WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy","volume":"19","author":"Hashemi","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0375","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/0886022X.2021.1936040","article-title":"ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte","volume":"43","author":"Yuan","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bbadis.2023.166714_bb0380","article-title":"Association of ANGPTL8 and resistin with diabetic nephropathy in type 2 diabetes mellitus","volume":"12","author":"Li","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2023.166714_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628950","article-title":"Dl-3-n-butylphthalide ameliorates diabetic nephropathy by ameliorating excessive fibrosis and podocyte apoptosis","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109625","article-title":"Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE\/RhoA\/ROCK signaling pathway","volume":"348","author":"Shu","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166714_bb0395","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/a-0998-7985","article-title":"Luteolin attenuates diabetic nephropathy through suppressing inflammatory response and oxidative stress by inhibiting STAT3 pathway","volume":"129","author":"Zhang","year":"2021","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.bbadis.2023.166714_bb0400","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3671751","article-title":"Prevention of streptozotocin-induced diabetic nephropathy by MG132: possible roles of Nrf2 and I\u03baB","volume":"2017","author":"Kong","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119649","article-title":"Therapeutic potential of AMPK signaling targeting in lung cancer: advances, challenges and future prospects","volume":"278","author":"Ashrafizadeh","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0410","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0415","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13880209.2021.2007269","article-title":"Britanin relieves ferroptosis-mediated myocardial ischaemia\/reperfusion damage by upregulating GPX4 through activation of AMPK\/GSK3\u03b2\/Nrf2 signalling","volume":"60","author":"Lu","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0420","article-title":"Huayu tongluo recipe attenuates renal oxidative stress and inflammation through the activation of AMPK\/Nrf2 signaling pathway in streptozotocin- (STZ-) induced diabetic rats","volume":"2021","author":"Li","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb0425","series-title":"Protective effects of chlorogenic acid against ischemia\/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties","first-page":"1249","volume":"23(10)","author":"Yun","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0430","series-title":"Chlorogenic acid improves ex vivo vessel function and protects endothelial cells against HOCl-induced oxidative damage, via increased production of nitric oxide and induction of Hmox-1","first-page":"53","volume":"27","author":"Jiang","year":"2016"},{"key":"10.1016\/j.bbadis.2023.166714_bb0435","series-title":"Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo","first-page":"68","volume":"46","author":"Yan","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0440","series-title":"Preparation and characterisation of chlorogenic acid-gelatin: a type of biologically active film for coating preservation","first-page":"657","volume":"221","author":"Fu","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0445","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2017.11.021","article-title":"Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2\/HO-1 and NF-\u0138B pathways","volume":"54","author":"Bao","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0450","article-title":"Tetrandrine modulates Rheb-mTOR signaling-mediated selective autophagy and protects pulmonary fibrosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0455","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7930396","article-title":"Tetrandrine ameliorates airway remodeling of chronic asthma by interfering TGF-\u03b21\/Nrf-2\/HO-1 signaling pathway-mediated oxidative stress","volume":"2019","author":"Lin","year":"2019","journal-title":"Can. Respir. J."},{"issue":"16","key":"10.1016\/j.bbadis.2023.166714_bb0460","doi-asserted-by":"crossref","first-page":"990","DOI":"10.21037\/atm-20-5548","article-title":"Tetrandrine mediates renal function and redox homeostasis in a streptozotocin-induced diabetic nephropathy rat model through Nrf2\/HO-1 reactivation","volume":"8","author":"Su","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0465","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/2211-5463.13251","article-title":"Isoeucommin a attenuates kidney injury in diabetic nephropathy through the Nrf2\/HO-1 pathway","volume":"11","author":"Huang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbadis.2023.166714_bb0470","series-title":"Systems biology analysis reveals role of MDM2 in diabetic nephropathy","volume":"1(17)","author":"Saito","year":"2016"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0475","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbamcr.2018.04.011","article-title":"MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease","volume":"1865","author":"Guo","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb0480","series-title":"Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties","first-page":"863","volume":"6(7)","author":"Deppe","year":"2010"},{"key":"10.1016\/j.bbadis.2023.166714_bb0485","series-title":"Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-\u03b3 in subtotal nephrectomized rat","first-page":"91","volume":"685(1-3)","author":"Toba","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0490","series-title":"Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-\u03b3\/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade","first-page":"308","volume":"59(2)","author":"Kusunoki","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0495","series-title":"Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse","first-page":"303","volume":"57(4)","author":"Okuno","year":"2010"},{"key":"10.1016\/j.bbadis.2023.166714_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120260","article-title":"Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2\/HO-1 signaling in diabetic rats","volume":"291","author":"Antar","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2023.166714_bb0505","series-title":"Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study","first-page":"e36041","volume":"7(5)","author":"Jim","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0510","series-title":"Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes","first-page":"1031","volume":"52(4)","author":"Dalla Vestra","year":"2003"},{"key":"10.1016\/j.bbadis.2023.166714_bb0515","series-title":"Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy","first-page":"225","volume":"55(1)","author":"Susztak","year":"2006"},{"key":"10.1016\/j.bbadis.2023.166714_bb0520","series-title":"Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment","first-page":"1","volume":"7(1)","author":"Siu","year":"2006"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0525","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10735-020-09904-6","article-title":"Down-regulation of SETD6 protects podocyte against high glucose and palmitic acid-induced apoptosis, and mitochondrial dysfunction via activating Nrf2-Keap1 signaling pathway in diabetic nephropathy","volume":"51","author":"Wang","year":"2020","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0530","series-title":"Sirtuin and metabolic kidney disease","first-page":"691","volume":"88(4)","author":"Wakino","year":"2015"},{"key":"10.1016\/j.bbadis.2023.166714_bb0535","series-title":"Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK\/SIRT1-independent pathway","first-page":"634","volume":"60(2)","author":"Kitada","year":"2011"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0540","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbamcr.2019.04.006","article-title":"P53\/NRF2 mediates SIRT1's protective effect on diabetic nephropathy","volume":"1866","author":"Ma","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb0545","series-title":"Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery","first-page":"621","volume":"134(3)","author":"Ellershaw","year":"2001"},{"key":"10.1016\/j.bbadis.2023.166714_bb0550","series-title":"Mechanism of action of hydralazine on vascular smooth muscle","first-page":"2915","volume":"33(18)","author":"Jacobs","year":"1984"},{"key":"10.1016\/j.bbadis.2023.166714_bb0555","series-title":"Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels","first-page":"43","volume":"361(1)","author":"Bang","year":"1998"},{"key":"10.1016\/j.bbadis.2023.166714_bb0560","series-title":"Acrolein Scavenger Hydralazine Prevents Streptozotocin-induced Painful Diabetic Neuropathy and Spinal Neuroinflammation in Rats","first-page":"1858","volume":"300(10)","author":"Yao","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0565","series-title":"Nephropathy in model combining genetic hypertension with experimental diabetes: enalapril versus hydralazine and metoprolol therapy","first-page":"1575","volume":"39(12)","author":"Cooper","year":"1990"},{"key":"10.1016\/j.bbadis.2023.166714_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113139","article-title":"Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy","volume":"151","author":"Chang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166714_bb0575","series-title":"Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K\/AKT signaling pathway in an osteoporosis model","first-page":"1","volume":"6(1)","author":"Ke","year":"2016"},{"key":"10.1016\/j.bbadis.2023.166714_bb0580","series-title":"Akebia saponin D attenuates ibotenic acid-induced cognitive deficits and pro-apoptotic response in rats: involvement of MAPK signal pathway","first-page":"479","volume":"101(3)","author":"Yu","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106467","article-title":"Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2\/HO-1 and inhibition of NF-KB pathway","volume":"84","author":"Lu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0590","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","article-title":"Oxidative stress and cancer: an overview","volume":"12","author":"Sosa","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0595","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1368-5031.2006.00825.x","article-title":"Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia","volume":"60","author":"Wright","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"Suppl","key":"10.1016\/j.bbadis.2023.166714_bb0600","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","article-title":"Oxidative stress in neurodegeneration: cause or consequence?","volume":"10","author":"Andersen","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0605","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201102095","article-title":"Signal transduction by reactive oxygen species","volume":"194","author":"Finkel","year":"2011","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0610","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408690490468489","article-title":"Antioxidants and prevention of chronic disease","volume":"44","author":"Willcox","year":"2004","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0615","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1208\/s12248-019-0301-6","article-title":"Moringa isothiocyanate activates Nrf2: potential role in diabetic nephropathy","volume":"21","author":"Cheng","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.bbadis.2023.166714_bb0620","doi-asserted-by":"crossref","first-page":"6151847","DOI":"10.1155\/2022\/6151847","article-title":"Trametenolic acid ameliorates the progression of diabetic nephropathy in db\/db mice via Nrf2\/HO-1 and NF-\u03baB-mediated pathways","volume":"2022","author":"Duan","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb0625","series-title":"Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats","first-page":"87","volume":"46(1)","author":"Akiyama","year":"2009"},{"key":"10.1016\/j.bbadis.2023.166714_bb0630","series-title":"Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes","first-page":"2779","volume":"73(12)","author":"Akiyama","year":"2009"},{"key":"10.1016\/j.bbadis.2023.166714_bb0635","series-title":"Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: content, and antioxidant, anti-diabetic and anti-hypertensive properties","first-page":"3187","volume":"8(9)","author":"Alu'Datt","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166714_bb0640","series-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models","first-page":"323","volume":"29(3)","author":"Parhiz","year":"2015"},{"key":"10.1016\/j.bbadis.2023.166714_bb0645","series-title":"Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats","first-page":"65","volume":"87","author":"Kumar","year":"2013"},{"key":"10.1016\/j.bbadis.2023.166714_bb0650","series-title":"Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats","first-page":"12868","volume":"17(11)","author":"Shi","year":"2012"},{"key":"10.1016\/j.bbadis.2023.166714_bb0655","series-title":"Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions","first-page":"814","volume":"52(7)","author":"Visnagri","year":"2014"},{"key":"10.1016\/j.bbadis.2023.166714_bb0660","series-title":"Involvement of the TGF\u03b21-ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy","first-page":"766","volume":"105","author":"Zhang","year":"2018"},{"key":"10.1016\/j.bbadis.2023.166714_bb0665","series-title":"Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro","first-page":"3713","volume":"14(4)","author":"Wang","year":"2017"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb0670","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb0675","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s11011-021-00785-6","article-title":"Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2\/ARE pathway","volume":"36","author":"Zhu","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbadis.2023.166714_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111552","article-title":"Hesperetin modulates the Sirt1\/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis","volume":"139","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166714_bb0685","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.biopha.2019.01.030","article-title":"Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2\/ARE\/glyoxalase 1 pathway","volume":"111","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166714_bb0690","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2147\/DDDT.S319260","article-title":"Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway","volume":"15","author":"Ma","year":"2021","journal-title":"Drug Des. Dev.Ther."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/toxics10070362","article-title":"Fenugreek seed galactomannan aqueous and extract protects against diabetic nephropathy and liver damage by targeting NF-\u03baB and Keap1\/Nrf2 axis","volume":"10","author":"Alsuliam","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.bbadis.2023.166714_bb0700","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.freeradbiomed.2017.04.365","article-title":"Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1","volume":"108","author":"Sun","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb0705","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2021.01.069","article-title":"Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt\/GSK-3\u03b2\/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation","volume":"544","author":"Feng","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb0710","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cbin.11599","article-title":"The role of transcription factor Ap1 in the activation of the Nrf2\/ARE pathway through TET1 in diabetic nephropathy","volume":"45","author":"Tan","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0715","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-16-0322","article-title":"Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC","volume":"232","author":"Dong","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0720","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5545193","article-title":"Berberine reduces renal cell pyroptosis in golden hamsters with diabetic nephropathy through the Nrf2-NLRP3-caspase-1-GSDMD pathway","volume":"2021","author":"Ding","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0725","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10565-019-09501-8","article-title":"Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy","volume":"36","author":"Du","year":"2020","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0730","doi-asserted-by":"crossref","DOI":"10.1177\/00368504221102751","article-title":"Rumex nervosus could alleviate streptozotocin-induced diabetic nephropathy in rats by activating Nrf2 signaling","volume":"105","author":"AlMousa","year":"2022","journal-title":"Sci. Prog."},{"key":"10.1016\/j.bbadis.2023.166714_bb0735","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7950457","article-title":"WJ-39, an aldose reductase inhibitor, ameliorates renal lesions in diabetic nephropathy by activating Nrf2 signaling","volume":"2020","author":"Zhou","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb0740","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3389\/fphar.2020.01119","article-title":"Sinapic acid ameliorates the progression of streptozotocin (STZ)-induced diabetic nephropathy in rats via NRF2\/HO-1 mediated pathways","volume":"11","author":"Alaofi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0745","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.12659\/MSM.915038","article-title":"Apigenin protects against renal tubular epithelial cell injury and oxidative stress by high glucose via regulation of NF-E2-related factor 2 (Nrf2) pathway","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbadis.2023.166714_bb0750","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2016.02.002","article-title":"Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy","volume":"93","author":"Cheng","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb0755","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.biopha.2018.08.002","article-title":"Omentin-1 protects renal function of mice with type 2 diabetic nephropathy via regulating miR-27a-Nrf2\/Keap1 axis","volume":"107","author":"Song","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0760","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1152\/ajpendo.00430.2012","article-title":"Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice","volume":"304","author":"Cui","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2023.166714_bb0765","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2016.07.019","article-title":"CKIP-1 ameliorates high glucose-induced expression of fibronectin and intercellular cell adhesion molecule-1 by activating the Nrf2\/ARE pathway in glomerular mesangial cells","volume":"116","author":"Gong","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101813","article-title":"Upregulation of BRD7 protects podocytes against high glucose-induced apoptosis by enhancing Nrf2 in a GSK-3\u03b2-dependent manner","volume":"76","author":"Yu","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbadis.2023.166714_bb0775","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.freeradbiomed.2015.08.009","article-title":"Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2","volume":"89","author":"Wu","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0780","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/tox.23441","article-title":"Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1\/Nrf2 signaling","volume":"37","author":"Xu","year":"2022","journal-title":"Environ. Toxicol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0785","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3892\/etm.2021.11091","article-title":"Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK\/Nrf2 signaling pathway","volume":"23","author":"Huang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb0790","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2019.03.007","article-title":"4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress","volume":"370","author":"Ma","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0795","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fct.2016.12.033","article-title":"Structured DAG oil ameliorates renal injury in streptozotocin-induced diabetic rats through inhibition of NF-\u03baB and activation of Nrf2 pathway","volume":"100","author":"Das","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0800","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/821936","article-title":"Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation","volume":"2012","author":"Cui","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"18","key":"10.1016\/j.bbadis.2023.166714_bb0805","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1042\/CS20191088","article-title":"Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function","volume":"134","author":"Li","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0810","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-013-3115-6","article-title":"Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-\u03baB\/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis","volume":"57","author":"Yang","year":"2014","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0815","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JME-17-0260","article-title":"SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy","volume":"60","author":"Zhang","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166714_bb0820","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phymed.2018.04.031","article-title":"Carnosic acid improves diabetic nephropathy by activating Nrf2\/ARE and inhibition of NF-\u03baB pathway","volume":"47","author":"Xie","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2023.166714_bb0825","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/291087","article-title":"Low-dose radiation activates Akt and Nrf2 in the kidney of diabetic mice: a potential mechanism to prevent diabetic nephropathy","volume":"2012","author":"Xing","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0830","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb0835","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0840","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb0845","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb0850","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1479164118787415","article-title":"The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis","volume":"15","author":"Bouthoorn","year":"2018","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0855","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00592-013-0455-0","article-title":"Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study","volume":"50","author":"Konduracka","year":"2013","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0860","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb0865","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0870","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-013-9377-8","article-title":"Metabolic dysfunction in diabetic cardiomyopathy","volume":"19","author":"Isfort","year":"2014","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0875","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-013-9388-5","article-title":"Structural changes in the myocardium during diabetes-induced cardiomyopathy","volume":"19","author":"Adeghate","year":"2014","journal-title":"Heart Fail. Rev."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0880","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","article-title":"Diabetic cardiomyopathy\u2013fact or fiction?","volume":"36","author":"Maisch","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.bbadis.2023.166714_bb0885","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2147\/VHRM.S11681","article-title":"Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies","volume":"6","author":"Voulgari","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb0890","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s11427-021-1982-8","article-title":"LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy","volume":"65","author":"Zhang","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb0895","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00125-022-05650-4","article-title":"Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice","volume":"65","author":"Qiu","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2023.166714_bb0900","article-title":"Capsaicin alleviates vascular endothelial dysfunction and cardiomyopathy via TRPV1\/eNOS pathway in diabetic rats","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0905","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0910","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb0915","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","article-title":"Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166714_bb0920","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21-sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2023.166714_bb0925","article-title":"Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes","author":"Ma","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0930","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7150\/ijbs.65938","article-title":"Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice","volume":"18","author":"Guo","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2023.166714_bb0935","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb0940","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0945","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0950","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41419-018-0307-5","article-title":"Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb0955","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s10753-018-0792-9","article-title":"Extracellular matrix remodeling and modulation of inflammation and oxidative stress by sulforaphane in experimental diabetic peripheral neuropathy","volume":"41","author":"Moustafa","year":"2018","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0960","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1538\/expanim.18-0146","article-title":"Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation","volume":"68","author":"Li","year":"2019","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbadis.2023.166714_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113273","article-title":"Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK\/Nrf2\/GPx4 axis","volume":"152","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166714_bb0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2022.01.005","article-title":"Sulforaphane improves cognitive dysfunction after surgery and anesthesia in mice: the role of Keap1-Nrf2 signaling","volume":"181","author":"Hua","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2023.166714_bb0975","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2022.10.001","article-title":"Sulforaphane promotes white matter plasticity and improves long-term neurological outcomes after ischemic stroke via the Nrf2 pathway","volume":"193","author":"Li","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2023.166714_bb0980","article-title":"Sulforaphane regulates Nrf2-mediated antioxidant activity and downregulates TGF-\u03b21\/Smad pathways to prevent radiation-induced muscle fibrosis","volume":"311","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2023.166714_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154002","article-title":"Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function","volume":"102","author":"Sun","year":"2020","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0990","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db15-1274","article-title":"Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy","volume":"66","author":"Gu","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb0995","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jcmm.14870","article-title":"Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats","volume":"24","author":"Luo","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166714_bb1000","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.2337\/db19-1176","article-title":"Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice","volume":"69","author":"Zang","year":"2020","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb1005","doi-asserted-by":"crossref","first-page":"H304","DOI":"10.1152\/ajpheart.00145.2017","article-title":"Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy","volume":"313","author":"Wang","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1010","series-title":"Targeted Regulation of Autophagy Using Nanoparticles: New Insight Into Cancer Therapy","first-page":"166326","volume":"1868(3)","author":"Paskeh","year":"2022"},{"key":"10.1016\/j.bbadis.2023.166714_bb1015","series-title":"Targeting Autophagy in Prostate Cancer: Preclinical and Clinical Evidence for Therapeutic Response","first-page":"1","volume":"41(1)","author":"Ashrafizadeh","year":"2022"},{"key":"10.1016\/j.bbadis.2023.166714_bb1020","series-title":"Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: potential applications in melanoma therapy","first-page":"19471","volume":"234(11)","author":"Ashrafizadeh","year":"2019"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb1025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1080\/15548627.2021.1974175","article-title":"m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin","volume":"18","author":"Liang","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb1030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/15548627.2021.1926655","article-title":"HMGB1 downregulation in retinal pigment epithelial cells protects against diabetic retinopathy through the autophagy-lysosome pathway","volume":"18","author":"Feng","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2023.166714_bb1035","series-title":"This old heart: Cardiac aging and autophagy","first-page":"44","volume":"83","author":"Linton","year":"2015"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb1040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2014.05.020","article-title":"Autophagy and mitophagy in diabetic cardiomyopathy","volume":"1852","author":"Kobayashi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2023.166714_bb1045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2013.10.014","article-title":"The interplay between autophagy and apoptosis in the diabetic heart","volume":"71","author":"Ouyang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.004","article-title":"Autophagy as an emerging target in cardiorenal metabolic disease: from pathophysiology to management","volume":"191","author":"Zhang","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13098-023-01026-9","article-title":"Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus","volume":"15","author":"Zhang","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166714_bb1060","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.4917","article-title":"Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile,AGEs and NO generation","volume":"27","author":"El-Bassossy","year":"2013","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bbadis.2023.166714_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.034","article-title":"Luteolin protects against diabetic cardiomyopathy by inhibiting NF-\u03baB-mediated inflammation and activating the Nrf2-mediated antioxidant responses","volume":"59","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166714_bb1070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00210-019-01777-1","article-title":"Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice","volume":"393","author":"Xian","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173387","article-title":"Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy","volume":"885","author":"Wang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1080","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7051845","article-title":"Resveratrol and diabetic cardiomyopathy: focusing on the protective signaling mechanisms","volume":"2020","author":"Song","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109767","article-title":"A review on the potential of resveratrol in prevention and therapy of diabetes and diabetic complications","volume":"125","author":"Huang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2023.166714_bb1090","article-title":"Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2023.166714_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113530","article-title":"Myricetin relieves the symptoms of type 2 diabetes mice and regulates intestinal microflora","volume":"153","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cbf.3442","article-title":"Myricetin ameliorates high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells","volume":"38","author":"Aminzadeh","year":"2020","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbadis.2023.166714_bb1105","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8370593","article-title":"Myricetin possesses potential protective effects on diabetic cardiomyopathy through inhibiting I\u03baB\u03b1\/NF\u03baB and enhancing Nrf2\/HO-1","volume":"2017","author":"Liao","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb1110","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200543RRR","article-title":"Curcumin activates Nrf2\/HO-1 signaling to relieve diabetic cardiomyopathy injury by reducing ROS in vitro and in vivo","volume":"36","author":"Wu","year":"2022","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1115","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/jcmm.13477","article-title":"An aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress","volume":"22","author":"You","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb1120","doi-asserted-by":"crossref","first-page":"H567","DOI":"10.1152\/ajpheart.00650.2012","article-title":"Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-\u03baB","volume":"304","author":"Wang","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1125","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3892\/etm.2017.4527","article-title":"Oleanolic acid protects against diabetic cardiomyopathy via modulation of the nuclear factor erythroid 2 and insulin signaling pathways","volume":"14","author":"Li","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174846","article-title":"Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway","volume":"920","author":"Wang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1135","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3773415","article-title":"Soluble epoxide hydrolase inhibition protected against diabetic cardiomyopathy through inducing autophagy and reducing apoptosis relying on Nrf2 upregulation and transcription activation","volume":"2022","author":"Fang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2018.05.121","article-title":"Fibroblast growth factor 19 protects the heart from oxidative stress-induced diabetic cardiomyopathy via activation of AMPK\/Nrf2\/HO-1 pathway","volume":"502","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2023.166714_bb1145","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3206542","article-title":"Bailcalin protects against diabetic cardiomyopathy through Keap1\/Nrf2\/AMPK-mediated antioxidative and lipid-lowering effects","volume":"2019","author":"Li","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb1150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fendo.2018.00774","article-title":"Phloretin prevents diabetic cardiomyopathy by dissociating Keap1\/Nrf2 complex and inhibiting oxidative stress","volume":"9","author":"Ying","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2023.166714_bb1155","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3159717","article-title":"Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway","volume":"2022","author":"Wei","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.bbadis.2023.166714_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153319","article-title":"Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress","volume":"78","author":"Gu","year":"2020","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3892\/ijmm.2017.3050","article-title":"Mulberry granules protect against diabetic cardiomyopathy through the AMPK\/Nrf2 pathway","volume":"40","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1170","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11854","article-title":"Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1\/Nrf2\/NF-\u03baB signalling pathway in diabetic cardiomyopathy rats","volume":"23","author":"Jin","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb1175","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2174\/1871530320666200420084444","article-title":"Exercise and stevia Rebaudiana (R) extracts attenuate diabetic cardiomyopathy in type 2 diabetic rats: possible underlying mechanisms","volume":"20","author":"Hussein","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.bbadis.2023.166714_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.022","article-title":"Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR\/Nrf2 signaling in db\/db mice","volume":"858","author":"Wu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1185","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2669","article-title":"Combination of dendrobium mixture and metformin curbs the development and progression of diabetic cardiomyopathy by targeting the lncRNA NEAT1","volume":"76","author":"Qin","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1190","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1038\/s41598-020-63498-3","article-title":"Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bbadis.2023.166714_bb1195","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213393","article-title":"KLF9 aggravates streptozotocin-induced diabetic cardiomyopathy by inhibiting PPAR\u03b3\/NRF2 signalling","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb1200","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1111\/jcmm.14520","article-title":"Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb1205","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fphar.2018.01227","article-title":"Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor \u03b1 and its downstream signaling","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.bbadis.2023.166714_bb1210","article-title":"Syringaresinol protects against type 1 diabetic cardiomyopathy by alleviating inflammation responses, cardiac fibrosis, and oxidative stress","volume":"64","author":"Li","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1215","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12170","article-title":"Guan Xin Dan Shen formulation protects db\/db mice against diabetic cardiomyopathy via activation of Nrf2 signaling","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2023.166714_bb1220","doi-asserted-by":"crossref","first-page":"30252","DOI":"10.1038\/srep30252","article-title":"Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db\/db T2DM mice","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166714_bb1225","doi-asserted-by":"crossref","first-page":"44239","DOI":"10.1038\/srep44239","article-title":"Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166714_bb1230","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3732718","article-title":"Bakuchiol alleviates hyperglycemia-induced diabetic cardiomyopathy by reducing myocardial oxidative stress via activating the SIRT1\/Nrf2 signaling pathway","volume":"2020","author":"Ma","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108754","article-title":"Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2\/HO-1 and NF-\u03baB pathways in diabetic cardiomyopathy","volume":"310","author":"Li","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2023.166714_bb1240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2013.01.008","article-title":"Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation","volume":"57","author":"Bai","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1245","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9086747","article-title":"Andrographolide ameliorates diabetic cardiomyopathy in mice by blockage of oxidative damage and NF-\u03baB-mediated inflammation","volume":"2018","author":"Liang","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb1250","series-title":"Diabetic neuropathy: clinical manifestations and current treatments","first-page":"521","volume":"11(6)","author":"Callaghan","year":"2012"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb1255","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.41.8.1315","article-title":"Prevalence of peripheral neuropathy in the Parsi community of Bombay","volume":"41","author":"Bharucha","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb1260","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1212\/WNL.43.6.1115","article-title":"Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group","volume":"43","author":"Savettieri","year":"1993","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb1265","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.27.7.1591","article-title":"Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999\u20132000 national health and nutrition examination survey","volume":"27","author":"Gregg","year":"2004","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166714_bb1270","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/diab.38.11.1456","article-title":"Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study","volume":"38","author":"Maser","year":"1989","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166714_bb1275","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00125-020-05085-9","article-title":"Diabetic neuropathy: what does the future hold?","volume":"63","author":"Callaghan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2023.166714_bb1280","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9524635","article-title":"Understanding diabetic neuropathy: focus on oxidative stress","volume":"2020","author":"Pang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2023.166714_bb1285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105985","article-title":"Lycorine improves peripheral nerve function by promoting schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy","volume":"175","author":"Yuan","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2023.166714_bb1290","article-title":"Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling","volume":"113","author":"Qureshi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1295","article-title":"Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy","author":"Jiao","year":"2022","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1300","first-page":"81","article-title":"Upregulation of TLR9 may contribute to activation of microglia and painful diabetic neuropathy via the p38 MAPK pathway in rats","volume":"37","author":"Niu","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1305","article-title":"Alpha-lipoic acid activates AMPK to protect against oxidative stress and apoptosis in rats with diabetic peripheral neuropathy","author":"Zhang","year":"2022","journal-title":"Hormones (Athens)"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb1310","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s11011-022-01060-y","article-title":"Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons","volume":"37","author":"Dastgheib","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbadis.2023.166714_bb1315","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8263999","article-title":"Isolation of thymol from Trachyspermum ammi fruits for treatment of diabetes and diabetic neuropathy in STZ-induced rats","volume":"2022","author":"Sachan","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166714_bb1320","article-title":"Naringin attenuates the diabetic neuropathy in STZ-induced type 2 diabetic Wistar rats","volume":"12","author":"Ahmad","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1325","doi-asserted-by":"crossref","first-page":"16730","DOI":"10.1038\/s41598-022-19947-2","article-title":"Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation","volume":"12","author":"Vieira","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166714_bb1330","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.997672","article-title":"Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2023.166714_bb1335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13813455.2022.2108454","article-title":"Activation of SIRT1 by silibinin improved mitochondrial health and alleviated the oxidative damage in experimental diabetic neuropathy and high glucose-mediated neurotoxicity","author":"Khan","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb1340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094887","article-title":"NAD(+) precursors repair mitochondrial function in diabetes and prevent experimental diabetic neuropathy","volume":"23","author":"Chandrasekaran","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb1345","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10571-020-00923-1","article-title":"SIRT1 activation by polydatin alleviates oxidative damage and elevates mitochondrial biogenesis in experimental diabetic neuropathy","volume":"41","author":"Bheereddy","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2023.166714_bb1350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-020-03758-y","article-title":"Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats","volume":"471","author":"Ganesan","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2023.166714_bb1355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jnutbio.2017.09.012","article-title":"Inhibition of vascular smooth muscle cells premature senescence with rutin attenuates and stabilizes diabetic atherosclerosis","volume":"51","author":"Li","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1360","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3892\/etm.2021.10376","article-title":"Rutin alleviates cardiomyocyte injury induced by high glucose through inhibiting apoptosis and endoplasmic reticulum stress","volume":"22","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2023.166714_bb1365","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2015.12.021","article-title":"Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via Nrf2 signaling pathway in rats","volume":"771","author":"Tian","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1370","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10787-017-0413-5","article-title":"Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2\/HO-1\/NF-kB and COX signalling pathway","volume":"26","author":"Mittal","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbadis.2023.166714_bb1375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fnins.2020.00241","article-title":"Fisetin prevents HT22 cells from high glucose-induced neurotoxicity via PI3K\/Akt\/CREB signaling pathway","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2023.166714_bb1380","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lfs.2019.02.017","article-title":"Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy","volume":"221","author":"Althunibat","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsps.2020.12.003","article-title":"Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R","volume":"29","author":"JZ","year":"2021","journal-title":"Saudi Pharm. J."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166714_bb1390","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10571-015-0272-9","article-title":"Fisetin imparts neuroprotection in experimental diabetic neuropathy by modulating Nrf2 and NF-\u03baB pathways","volume":"36","author":"Sandireddy","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.bbadis.2023.166714_bb1395","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.18632\/aging.202830","article-title":"Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2023.166714_bb1400","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2018.04.017","article-title":"Protective effects of sulforaphane on cognitive impairments and AD-like lesions in diabetic mice are associated with the upregulation of Nrf2 transcription activity","volume":"381","author":"Pu","year":"2018","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166714_bb1405","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1152\/ajpendo.00702.2013","article-title":"Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function","volume":"307","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166714_bb1410","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/156720211798120972","article-title":"Nrf2 and NF-\u03baB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes","volume":"8","author":"Negi","year":"2011","journal-title":"Curr. Neurovasc. Res."},{"issue":"14","key":"10.1016\/j.bbadis.2023.166714_bb1415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144850","article-title":"Bergenin reduces experimental painful diabetic neuropathy by restoring redox and immune homeostasis in the nervous system","volume":"21","author":"Villarreal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166714_bb1420","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1159\/000491983","article-title":"The natural rotenoid deguelin ameliorates diabetic neuropathy by decreasing oxidative stress and plasma glucose levels in rats via the Nrf2 signalling pathway","volume":"48","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166714_bb1425","first-page":"10112","article-title":"Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb1430","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-079X.2010.00821.x","article-title":"Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-\u03baB and Nrf2 cascades","volume":"50","author":"Negi","year":"2011","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166714_bb1435","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/biof.1397","article-title":"Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy","volume":"44","author":"Bachewal","year":"2018","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166714_bb1440","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1007\/s12035-020-01989-0","article-title":"Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy","volume":"57","author":"Kalvala","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2023.166714_bb1445","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jnutbio.2017.05.001","article-title":"Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy","volume":"47","author":"Yerra","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbadis.2023.166714_bb1450","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106392","article-title":"Anti-neuropathic pain activity of ajugarin-I via activation of Nrf2 signaling and inhibition of TRPV1\/TRPM8 nociceptors in STZ-induced diabetic neuropathy","volume":"183","author":"Khan","year":"2022","journal-title":"Pharmacol. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T22:14:51Z","timestamp":1717280091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":290,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0925443923000807"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166714","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166714"}}